Viriditas is Latin for viridity and growth. The company is committed to STEM (Science, Technology, Engineering and Mathematics) and medical research and development with its core function being to develop the next generation of innovative bioscience and biotechnology techniques and products.Plant families such as the Amaryllidaceae, Brassicaceae, Cannabaceae, Ericaceae, Iridaceae, Lamiaceae, Lauraceae, Moringaceae, Pandanaceae, Poaceae, Rutaceae, Zingiberaceae, etc. and their multitude of genera and species offer a wide range and wealth of unique properties through their leaves, seeds, fruits, roots, bulbs, bark, stems and even waste for uses in a variety of areas such as:

• Biopharmaceutical
• Medical and Biomedicine
• Health and Beauty
• Agriculture and Digital Farming feeding into the Consumer Industry
• Construction and the Built Environment
• Energy, Environment and Climate Change which includes next generation of biofuels

Much of the plants structure from its roots to its shoots from plants such as garlic, broccoli, kale, cannabis, blueberries, saffron, mint, lavender, bay leaves, avocado, moringa, pandan, barley, lemongrass, curry leaves, pomelo, lime, ginger, turmeric to name a few, can be processed to extract vast amounts of proteins, minerals and vitamins but more importantly other phytochemical or chemical compounds for uses in medicine and health.Viriditas is actively researching plants for their naturally occurring antioxidant, antibacterial, antiviral, anti-inflammatory, anti-depressive antipyretic, antiemetic, anticarcinogenic and analgesic properties and effects through their compounds like for instance; sulphoranes, allium Sulphur, anthocyanins, catechins, beta-carotenes, thiols and cannabinoids (CBD — cannabidiol, CBC — cannabichromene, CBG — cannbigerol, CBL — cannabicyclol, CBT — cannabicitran, etc.).

Viriditas is Latin for viridity and growth. The company is committed to STEM (Science, Technology, Engineering and Mathematics) and medical research and development with its core function being to develop the next generation of innovative bioscience and biotechnology techniques and products.

Plant families such as the Amaryllidaceae, Brassicaceae, Cannabaceae, Ericaceae, Iridaceae, Lamiaceae, Lauraceae, Moringaceae, Pandanaceae, Poaceae, Rutaceae, Zingiberaceae, etc. and their multitude of genera and species offer a wide range and wealth of unique properties through their leaves, seeds, fruits, roots, bulbs, bark, stems and even waste for uses in a variety of areas such as:

• Biopharmaceutical
• Medical and Biomedicine
• Health and Beauty
• Agriculture and Digital Farming feeding into the Consumer Industry
• Construction and the Built Environment
• Energy, Environment and Climate Change which includes next generation of biofuels

Much of the plants structure from its roots to its shoots from plants such as garlic, broccoli, kale, cannabis, blueberries, saffron, mint, lavender, bay leaves, avocado, moringa, pandan, barley, lemongrass, curry leaves, pomelo, lime, ginger, turmeric to name a few, can be processed to extract vast amounts of proteins, minerals and vitamins but more importantly other phytochemical or chemical compounds for uses in medicine and health. Viriditas is actively researching plants for their naturally occurring antioxidant, antibacterial, antiviral, anti-inflammatory, anti-depressive antipyretic, antiemetic, anticarcinogenic and analgesic properties and effects through their compounds like for instance; sulphoranes, allium Sulphur, anthocyanins, catechins, beta-carotenes, thiols and cannabinoids (CBD – cannabidiol, CBC – cannabichromene, CBG – cannbigerol, CBL – cannabicyclol, CBT – cannabicitran, etc.).

Due to the need, demand and growth in these sectors, Viriditas is developing homegrown jobs and wealth creation and IPR generation in Malaysia through its founding and by key and distinct academic and industrial research partnerships that thrive on innovation in research areas such as:

• Growth and harvesting technologies and techniques in plant cultivation and agriculture
• Environmentally friendly and safe for human use cosmetic products such as perfumes, deodorants, etc.
• Medical treatments and pharmaceutical development of drugs for but not limited to:

• Parkinson’s Disease
• Alzheimer’s and Dementia
• Autism
• Diabetes
• Depression, stress and anxiety
• Multiple Sclerosis and Motor Neuron Disease
• Cancers and effects of conventional cancer treatments such as chemotherapy and radiotherapy
• Diagnostic tools and sensors
• Pain relief
• Health supplements for general health and ailments

As a further objective, Viriditas will invest in research and facilities to take full advantage of plant-based materials and exploit their properties over the course of their life cycle from cultivation to waste so that the company can operate as a GREEN company. Through this research and investment plan, the company looks to discover, innovate and develop further, findings and products that could have a direct impact on the Energy and Built Environment sectors to enable a further step to a reduction in carbon footprints that these sectors create and reliance on fossil fuels.

It is a key priority of Viriditas to engage in the local and regional research community to enable and develop Malaysia as a world player and leader in the biosciences and biotechnologies sector through expertise and export of products developed from the research and development programs.

The key output and task post research, will be to disseminate the information gathered and found through observation. Viriditas is working with government ministries, departments, and agencies as well as non- governmental organisations to educate and inform policy makers and advisors for the development of standards and regulations, particularly in the medical, pharmaceutical and agricultural sectors. Viriditas will prioritise the dissemination of accurate information to the public based on sound and diligent scientific integrity. Viriditas aspires to become a leader in research and product development with an ethos of validating and verifying with integrity.

Viriditas has been formed to participate in the burgeoning global market for plant-based materials and extracts.

The global demand for these products is growing at a phenomenal rate backed by STEM (Science, Technology, Engineering and Mathematics) and medical research.

Based in Malaysia, Viriditas is engaged at various levels of Government and research institutions in developing regulatory framework and standards. Thus enabling Malaysia to become the leading provider of plant based bioscience and biotechnical products such as medical, health and pharmaceutical products for the Asian and global markets, developed from a wide range of extracted, naturally occurring materials such as compounds, oils, enzymes, proteins and other phytochemicals.

Viriditas has the expert knowledge and research capabilities to enable multiple product line development for export and home consumption.

Viriditas is Latin for viridity and growth. The company is committed to STEM (Science, Technology, Engineering and Mathematics) and medical research and development with its core function being to develop the next generation of innovative bioscience and biotechnology techniques and products.

Plant families such as the Amaryllidaceae, Brassicaceae, Cannabaceae, Ericaceae, Iridaceae, Lamiaceae, Lauraceae, Moringaceae, Pandanaceae, Poaceae, Rutaceae, Zingiberaceae, etc. and their multitude of genera and species offer a wide range and wealth of unique properties through their leaves, seeds, fruits, roots, bulbs, bark, stems and even waste for uses in a variety of areas such as:

• Biopharmaceutical
• Medical and Biomedicine
• Health and Beauty
• Agriculture and Digital Farming feeding into the Consumer Industry
• Construction and the Built Environment
• Energy, Environment and Climate Change which includes next generation of biofuels

Much of the plants structure from its roots to its shoots from plants such as garlic, broccoli, kale, cannabis, blueberries, saffron, mint, lavender, bay leaves, avocado, moringa, pandan, barley, lemongrass, curry leaves, pomelo, lime, ginger, turmeric to name a few, can be processed to extract vast amounts of proteins, minerals and vitamins but more importantly other phytochemical or chemical compounds for uses in medicine and health. Viriditas is actively researching plants for their naturally occurring antioxidant, antibacterial, antiviral, anti-inflammatory, anti-depressive antipyretic, antiemetic, anticarcinogenic and analgesic properties and effects through their compounds like for instance; sulphoranes, allium Sulphur, anthocyanins, catechins, beta-carotenes, thiols and cannabinoids (CBD – cannabidiol, CBC – cannabichromene, CBG – cannbigerol, CBL – cannabicyclol, CBT – cannabicitran, etc.).

Due to the need, demand and growth in these sectors, Viriditas is developing homegrown jobs and wealth creation and IPR generation in Malaysia through its founding and by key and distinct academic and industrial research partnerships that thrive on innovation in research areas such as:

• Growth and harvesting technologies and techniques in plant cultivation and agriculture
• Environmentally friendly and safe for human use cosmetic products such as perfumes, deodorants, etc.
• Medical treatments and pharmaceutical development of drugs for but not limited to:

• Parkinson’s Disease
• Alzheimer’s and Dementia
• Autism
• Diabetes
• Depression, stress and anxiety
• Multiple Sclerosis and Motor Neuron Disease
• Cancers and effects of conventional cancer treatments such as chemotherapy and radiotherapy
• Diagnostic tools and sensors
• Pain relief
• Health supplements for general health and ailments

As a further objective, Viriditas will invest in research and facilities to take full advantage of plant-based materials and exploit their properties over the course of their life cycle from cultivation to waste so that the company can operate as a GREEN company. Through this research and investment plan, the company looks to discover, innovate and develop further, findings and products that could have a direct impact on the Energy and Built Environment sectors to enable a further step to a reduction in carbon footprints that these sectors create and reliance on fossil fuels.

It is a key priority of Viriditas to engage in the local and regional research community to enable and develop Malaysia as a world player and leader in the biosciences and biotechnologies sector through expertise and export of products developed from the research and development programs.

The key output and task post research, will be to disseminate the information gathered and found through observation. Viriditas is working with government ministries, departments, and agencies as well as non- governmental organisations to educate and inform policy makers and advisors for the development of standards and regulations, particularly in the medical, pharmaceutical and agricultural sectors. Viriditas will prioritise the dissemination of accurate information to the public based on sound and diligent scientific integrity. Viriditas aspires to become a leader in research and product development with an ethos of validating and verifying with integrity.

Viriditas has been formed to participate in the burgeoning global market for plant-based materials and extracts.

The global demand for these products is growing at a phenomenal rate backed by STEM (Science, Technology, Engineering and Mathematics) and medical research.

Based in Malaysia, Viriditas is engaged at various levels of Government and research institutions in developing regulatory framework and standards.

Thus enabling Malaysia to become the leading provider of plant based bioscience and biotechnical products such as medical, health and pharmaceutical products for the Asian and global markets, developed from a wide range of extracted, naturally occurring materials such as compounds, oils, enzymes, proteins and other phytochemicals.

Viriditas has the expert knowledge and research capabilities to enable multiple product line development for export and home consumption.

Viriditas is Latin for viridity and growth. The company is committed to STEM (Science, Technology, Engineering and Mathematics) and medical research and development with its core function being to develop the next generation of innovative bioscience and biotechnology techniques and products.

Plant families such as the Amaryllidaceae, Brassicaceae, Cannabaceae, Ericaceae, Iridaceae, Lamiaceae, Lauraceae, Moringaceae, Pandanaceae, Poaceae, Rutaceae, Zingiberaceae, etc. and their multitude of genera and species offer a wide range and wealth of unique properties through their leaves, seeds, fruits, roots, bulbs, bark, stems and even waste for uses in a variety of areas such as:

• Biopharmaceutical
• Medical and Biomedicine
• Health and Beauty
• Agriculture and Digital Farming feeding into the Consumer Industry
• Construction and the Built Environment
• Energy, Environment and Climate Change which includes next generation of biofuels

Much of the plants structure from its roots to its shoots from plants such as garlic, broccoli, kale, cannabis, blueberries, saffron, mint, lavender, bay leaves, avocado, moringa, pandan, barley, lemongrass, curry leaves, pomelo, lime, ginger, turmeric to name a few, can be processed to extract vast amounts of proteins, minerals and vitamins but more importantly other phytochemical or chemical compounds for uses in medicine and health. Viriditas is actively researching plants for their naturally occurring antioxidant, antibacterial, antiviral, anti-inflammatory, anti-depressive antipyretic, antiemetic, anticarcinogenic and analgesic properties and effects through their compounds like for instance; sulphoranes, allium Sulphur, anthocyanins, catechins, beta-carotenes, thiols and cannabinoids (CBD – cannabidiol, CBC – cannabichromene, CBG – cannbigerol, CBL – cannabicyclol, CBT – cannabicitran, etc.).

Due to the need, demand and growth in these sectors, Viriditas is developing homegrown jobs and wealth creation and IPR generation in Malaysia through its founding and by key and distinct academic and industrial research partnerships that thrive on innovation in research areas such as:

• Growth and harvesting technologies and techniques in plant cultivation and agriculture
• Environmentally friendly and safe for human use cosmetic products such as perfumes, deodorants, etc.
• Medical treatments and pharmaceutical development of drugs for but not limited to:

• Parkinson’s Disease
• Alzheimer’s and Dementia
• Autism
• Diabetes
• Depression, stress and anxiety
• Multiple Sclerosis and Motor Neuron Disease
• Cancers and effects of conventional cancer treatments such as chemotherapy and radiotherapy
• Diagnostic tools and sensors
• Pain relief
• Health supplements for general health and ailments

As a further objective, Viriditas will invest in research and facilities to take full advantage of plant-based materials and exploit their properties over the course of their life cycle from cultivation to waste so that the company can operate as a GREEN company. Through this research and investment plan, the company looks to discover, innovate and develop further, findings and products that could have a direct impact on the Energy and Built Environment sectors to enable a further step to a reduction in carbon footprints that these sectors create and reliance on fossil fuels.

It is a key priority of Viriditas to engage in the local and regional research community to enable and develop Malaysia as a world player and leader in the biosciences and biotechnologies sector through expertise and export of products developed from the research and development programs.

The key output and task post research, will be to disseminate the information gathered and found through observation. Viriditas is working with government ministries, departments, and agencies as well as non- governmental organisations to educate and inform policy makers and advisors for the development of standards and regulations, particularly in the medical, pharmaceutical and agricultural sectors. Viriditas will prioritise the dissemination of accurate information to the public based on sound and diligent scientific integrity. Viriditas aspires to become a leader in research and product development with an ethos of validating and verifying with integrity.

Viriditas has been formed to participate in the burgeoning global market for plant-based materials and extracts.
The global demand for these products is growing at a phenomenal rate backed by STEM (Science, Technology, Engineering and Mathematics) and medical research.
Based in Malaysia, Viriditas is engaged at various levels of Government and research institutions in developing regulatory framework and standards. Thus enabling Malaysia to become the leading provider of plant based bioscience and biotechnical products such as medical, health and pharmaceutical products for the Asian and global markets, developed from a wide range of extracted, naturally occurring materials such as compounds, oils, enzymes, proteins and other phytochemicals.
Viriditas has the expert knowledge and research capabilities to enable multiple product line development for export and home consumption.

Viriditas is Latin for viridity and growth. The company is committed to STEM (Science, Technology, Engineering and Mathematics) and medical research and development with its core function being to develop the next generation of innovative bioscience and biotechnology techniques and products.

Plant families such as the Amaryllidaceae, Brassicaceae, Cannabaceae, Ericaceae, Iridaceae, Lamiaceae, Lauraceae, Moringaceae, Pandanaceae, Poaceae, Rutaceae, Zingiberaceae, etc. and their multitude of genera and species offer a wide range and wealth of unique properties through their leaves, seeds, fruits, roots, bulbs, bark, stems and even waste for uses in a variety of areas such as:

• Biopharmaceutical
• Medical and Biomedicine
• Health and Beauty
• Agriculture and Digital Farming feeding into the Consumer Industry
• Construction and the Built Environment
• Energy, Environment and Climate Change which includes next generation of biofuels

Much of the plants structure from its roots to its shoots from plants such as garlic, broccoli, kale, cannabis, blueberries, saffron, mint, lavender, bay leaves, avocado, moringa, pandan, barley, lemongrass, curry leaves, pomelo, lime, ginger, turmeric to name a few, can be processed to extract vast amounts of proteins, minerals and vitamins but more importantly other phytochemical or chemical compounds for uses in medicine and health. Viriditas is actively researching plants for their naturally occurring antioxidant, antibacterial, antiviral, anti-inflammatory, anti-depressive antipyretic, antiemetic, anticarcinogenic and analgesic properties and effects through their compounds like for instance; sulphoranes, allium Sulphur, anthocyanins, catechins, beta-carotenes, thiols and cannabinoids (CBD – cannabidiol, CBC – cannabichromene, CBG – cannbigerol, CBL – cannabicyclol, CBT – cannabicitran, etc.).

Due to the need, demand and growth in these sectors, Viriditas is developing homegrown jobs and wealth creation and IPR generation in Malaysia through its founding and by key and distinct academic and industrial research partnerships that thrive on innovation in research areas such as:

• Growth and harvesting technologies and techniques in plant cultivation and agriculture
• Environmentally friendly and safe for human use cosmetic products such as perfumes, deodorants, etc.
• Medical treatments and pharmaceutical development of drugs for but not limited to:

• Parkinson’s Disease
• Alzheimer’s and Dementia
• Autism
• Diabetes
• Depression, stress and anxiety
• Multiple Sclerosis and Motor Neuron Disease
• Cancers and effects of conventional cancer treatments such as chemotherapy and radiotherapy
• Diagnostic tools and sensors
• Pain relief
• Health supplements for general health and ailments

As a further objective, Viriditas will invest in research and facilities to take full advantage of plant-based materials and exploit their properties over the course of their life cycle from cultivation to waste so that the company can operate as a GREEN company. Through this research and investment plan, the company looks to discover, innovate and develop further, findings and products that could have a direct impact on the Energy and Built Environment sectors to enable a further step to a reduction in carbon footprints that these sectors create and reliance on fossil fuels.

It is a key priority of Viriditas to engage in the local and regional research community to enable and develop Malaysia as a world player and leader in the biosciences and biotechnologies sector through expertise and export of products developed from the research and development programs.

The key output and task post research, will be to disseminate the information gathered and found through observation. Viriditas is working with government ministries, departments, and agencies as well as non- governmental organisations to educate and inform policy makers and advisors for the development of standards and regulations, particularly in the medical, pharmaceutical and agricultural sectors. Viriditas will prioritise the dissemination of accurate information to the public based on sound and diligent scientific integrity. Viriditas aspires to become a leader in research and product development with an ethos of validating and verifying with integrity.

Viriditas has been formed to participate in the burgeoning global market for plant-based materials and extracts.

The global demand for these products is growing at a phenomenal rate backed by STEM (Science, Technology, Engineering and Mathematics) and medical research.

Based in Malaysia, Viriditas is engaged at various levels of Government and research institutions in developing regulatory framework and standards. Thus enabling Malaysia to become the leading provider of plant based bioscience and biotechnical products such as medical, health and pharmaceutical products for the Asian and global markets, developed from a wide range of extracted, naturally occurring materials such as compounds, oils, enzymes, proteins and other phytochemicals.

Viriditas has the expert knowledge and research capabilities to enable multiple product line development for export and home consumption.

Viriditas is Latin for viridity and growth. The company is committed to STEM (Science, Technology, Engineering and Mathematics) and medical research and development with its core function being to develop the next generation of innovative bioscience and biotechnology techniques and products.
Plant families such as the Amaryllidaceae, Brassicaceae, Cannabaceae, Ericaceae, Iridaceae, Lamiaceae, Lauraceae, Moringaceae, Pandanaceae, Poaceae, Rutaceae, Zingiberaceae, etc. and their multitude of genera and species offer a wide range and wealth of unique properties through their leaves, seeds, fruits, roots, bulbs, bark, stems and even waste for uses in a variety of areas such as:

• Biopharmaceutical
• Medical and Biomedicine
• Health and Beauty
• Agriculture and Digital Farming feeding into the Consumer Industry
• Construction and the Built Environment
• Energy, Environment and Climate Change which includes next generation of biofuels

   Much of the plants structure from its roots to its shoots from plants such as garlic, broccoli, kale, cannabis, blueberries, saffron, mint, lavender, bay leaves, avocado, moringa, pandan, barley, lemongrass, curry leaves, pomelo, lime, ginger, turmeric to name a few, can be processed to extract vast amounts of proteins, minerals and vitamins but more importantly other phytochemical or chemical compounds for uses in medicine and health. Viriditas is actively researching plants for their naturally occurring antioxidant, antibacterial, antiviral, anti-inflammatory, anti-depressive antipyretic, antiemetic, anticarcinogenic and analgesic properties and effects through their compounds like for instance; sulphoranes, allium Sulphur, anthocyanins, catechins, beta-carotenes, thiols and cannabinoids (CBD – cannabidiol, CBC – cannabichromene, CBG – cannbigerol, CBL – cannabicyclol, CBT – cannabicitran, etc.).
Due to the need, demand and growth in these sectors, Viriditas is developing homegrown jobs and wealth creation and IPR generation in Malaysia through its founding and by key and distinct academic and industrial research partnerships that thrive on innovation in research areas such as:

• Growth and harvesting technologies and techniques in plant cultivation and agriculture
• Environmentally friendly and safe for human use cosmetic products such as perfumes, deodorants, etc.
• Medical treatments and pharmaceutical development of drugs for but not limited to:
• Parkinson’s Disease
• Alzheimer’s and Dementia
• Autism
• Diabetes
• Depression, stress and anxiety
• Multiple Sclerosis and Motor Neuron Disease
• Cancers and effects of conventional cancer treatments such as chemotherapy and radiotherapy
• Diagnostic tools and sensors
• Pain relief
• Health supplements for general health and ailments

 As a further objective, Viriditas will invest in research and facilities to take full advantage of plant-based materials and exploit their properties over the course of their life cycle from cultivation to waste so that the company can operate as a GREEN company. Through this research and investment plan, the company looks to discover, innovate and develop further, findings and products that could have a direct impact on the Energy and Built Environment sectors to enable a further step to a reduction in carbon footprints that these sectors create and reliance on fossil fuels.It is a key priority of Viriditas to engage in the local and regional research community to enable and develop Malaysia as a world player and leader in the biosciences and biotechnologies sector through expertise and export of products developed from the research and development programs.
The key output and task post research, will be to disseminate the information gathered and found through observation. Viriditas is working with government ministries, departments, and agencies as well as non- governmental organisations to educate and inform policy makers and advisors for the development of standards and regulations, particularly in the medical, pharmaceutical and agricultural sectors. Viriditas will prioritise the dissemination of accurate information to the public based on sound and diligent scientific integrity. Viriditas aspires to become a leader in research and product development with an ethos of validating and verifying with integrity.